ribavirin has been researched along with tyramine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Haegeman, G; Junking, M; Limjindaporn, T; Panya, A; Rattanaburee, T; Sawasdee, N; Songprakhon, P; Suttitheptumrong, A; Yenchitsomanus, PT | 1 |
1 review(s) available for ribavirin and tyramine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for ribavirin and tyramine
| Article | Year |
|---|---|
Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Antiviral Agents; Cell Line, Tumor; Chemokines; Cytokines; Dengue; Dengue Virus; Drug Synergism; Humans; Ribavirin; Tyramine; Vero Cells; Virus Replication | 2015 |